While Elanco Animal Health Inc has underperformed by -0.86%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ELAN rose by 81.59%, with highs and lows ranging from $23.70 to $8.02, whereas the simple moving average jumped by 42.12% in the last 200 days.
On November 21, 2025, KeyBanc Capital Markets started tracking Elanco Animal Health Inc (NYSE: ELAN) recommending Overweight. A report published by Argus on November 19, 2025, Upgraded its rating to ‘Buy’ for ELAN. JP Morgan also Upgraded ELAN shares as ‘Overweight’, setting a target price of $24 on the company’s shares in a report dated October 07, 2025. William Blair June 26, 2025d its ‘Mkt Perform’ rating to ‘Outperform’ for ELAN, as published in its report on June 26, 2025. UBS’s report from December 09, 2024 suggests a price prediction of $18 for ELAN shares, giving the stock a ‘Buy’ rating. Leerink Partners also rated the stock as ‘Market Perform’.
Analysis of Elanco Animal Health Inc (ELAN)
Further, the quarter-over-quarter increase in sales is 10.39%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Elanco Animal Health Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 0.54% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.23, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and ELAN is recording an average volume of 5.40M. On a monthly basis, the volatility of the stock is set at 3.54%, whereas on a weekly basis, it is put at 2.50%, with a loss of -5.66% over the past seven days. Furthermore, long-term investors anticipate a median target price of $24.67, showing growth from the present price of $21.99, which can serve as yet another indication of whether ELAN is worth investing in or should be passed over.
How Do You Analyze Elanco Animal Health Inc Shares?
A leading company in the Drug Manufacturers – Specialty & Generic sector, Elanco Animal Health Inc (ELAN) is based in the USA. When comparing Elanco Animal Health Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 301.65, there is a growth in quarterly earnings of -109.35%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.83%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 115.67% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
